Komori
SanBio (4592) · InitiativeRestated

Development risk management using scientific advisors and senior advisors

First written in FY2017. 2 of 4 entries say "Restated". Latest entry: FY2023.

4entries
7years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2017 – FY2019AdvancedFY20202017: 120172018: 020182019: 120192020: 120202021: 020212022: 020222023: 12023
Same theme, other companies
Development risk management through scientific advisers and expert networksA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2023RestatedAnnual report

    「To address these risks, we have established a framework for working with our founding scientist and the above network, which possess cutting-edge scientific knowledge. We consult them as necessary and work to manage risk.」

    The framework for managing the risks associated with technological innovation and unforeseen adverse effects through collaboration with the founding scientist and the expert network has been reaffirmed.
  2. FY2020AdvancedAnnual report

    「In addition to Professor Hideyuki Okano of Keio University, who is also a founding scientist, our Group has established a framework that enables it to incorporate the expertise of a network including a former director of the U.S. National Institute on Aging, a former commissioner of the U.S. Food and Drug Administration, and a discoverer of mesenchymal stem cells into development activities.」

    In addition to collaboration with its existing scientific advisors and others, the company specifically described the use of an expert network including a former director of the NIH, a former FDA commissioner and a discoverer of mesenchymal stem cells.
  3. FY2019RestatedAnnual report

    「To address these risks, we have established a framework for working with our founding scientist, scientific advisors and senior advisors, who possess cutting-edge scientific knowledge. We consult them as necessary and work to manage risk.」

    The framework for managing the risks associated with technological innovation and unforeseen adverse effects through collaboration with scientific advisors, senior advisors and others has been reaffirmed.
  4. FY2017First statedAnnual report

    「To address these risks, we have established a framework for working with our founding scientist, scientific advisors and senior advisors, who possess cutting-edge scientific knowledge. We consult them as necessary and work to manage risk.」

    A framework has been established to work with scientific advisors and others in addressing the risks of technological innovation and unforeseen adverse effects.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for SanBio yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Development risk management using scientific advisors and senior advisors | SanBio Company Limited (4592) | Komori